The United States Anti-Doping Agency (USADA) announced Friday that UFC light heavyweight fighter Ovince St. Preux has accepted a three month retroactive suspension for a Nov. 1 2019 out-of-competition positive test.
The test contained ostarine and di-hydroxy-LGD-4033, a metabolite of LGD-4033, as well GW1516 sulfone and GW1516 sulfoxide, which are metabolites of GW1516 (also known as GW-501516). According to the UFC anti-doping policy, these substances are banned.
A USADA investigation revealed that the substances in question came from contaminated supplements, which did not list the substances. Because St. Preux did not intentionally ingest them, he was determined to be not at fault and factored into the reduction of his sanction.
St. Preux’s exposure was considered to have begun on Oct. 25, 2019, which means the three month suspension ended on Jan. 25. St. Preux is now eligible for competition in the octagon. His last bout was a submission win over Michal Oleksiwjczuk at UFC on ESPN+ 18 in September 2019.